IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Medicxi Ventures Management (Jersey) Ltd

Q2 2026 Holdings

Filed 2026-08-04 | 3 holdings | $177.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$81.0M7,464,57245.6%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$74.9M2,208,63942.2%
Aura Biosciences Inc(AURA)COM05153U107$21.6M3,039,89212.2%